271 related articles for article (PubMed ID: 7685668)
1. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).
Vassilev T; Gelin C; Kaveri SV; Zilber MT; Boumsell L; Kazatchkine MD
Clin Exp Immunol; 1993 Jun; 92(3):369-72. PubMed ID: 7685668
[TBL] [Abstract][Full Text] [Related]
2. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
[TBL] [Abstract][Full Text] [Related]
3. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
Mouthon L; Kaveri S; Kazatchkine M
Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins and the regulation of autoimmunity through the immune network.
Lacroix-Desmazes S; Mouthon L; Spalter SH; Kaveri S; Kazatchkine MD
Clin Exp Rheumatol; 1996; 14 Suppl 15():S9-15. PubMed ID: 8828942
[TBL] [Abstract][Full Text] [Related]
5. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
Dietrich G; Kaveri SV; Kazatchkine MD
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L
J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
[TBL] [Abstract][Full Text] [Related]
7. Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.
Bouhlal H; Martinvalet D; Teillaud JL; Fridman C; Kazatchkine MD; Bayry J; Lacroix-Desmazes S; Kaveri SV
J Clin Immunol; 2014 Jul; 34 Suppl 1():S4-11. PubMed ID: 24682714
[TBL] [Abstract][Full Text] [Related]
8. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
9. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
10. IVIG regulates the survival of human but not mouse neutrophils.
Schneider C; Wicki S; Graeter S; Timcheva TM; Keller CW; Quast I; Leontyev D; Djoumerska-Alexieva IK; Käsermann F; Jakob SM; Dimitrova PA; Branch DR; Cummings RD; Lünemann JD; Kaufmann T; Simon HU; von Gunten S
Sci Rep; 2017 May; 7(1):1296. PubMed ID: 28465620
[TBL] [Abstract][Full Text] [Related]
11. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Klaesson S; Ringdén O; Markling L; Remberger M; Lundkvist I
Scand J Immunol; 1993 Nov; 38(5):477-84. PubMed ID: 8235451
[TBL] [Abstract][Full Text] [Related]
12. Low affinity binding of mouse immunoglobulin to human CD5+ B cells.
Weston KM; Raison RL
Immunol Cell Biol; 1991 Aug; 69 ( Pt 4)():261-71. PubMed ID: 1723967
[TBL] [Abstract][Full Text] [Related]
13. Antiidiotypic suppression of autoantibodies with normal polyspecific immunoglobulins.
Rossi F; Dietrich G; Kazatchkine MD
Res Immunol; 1989 Jan; 140(1):19-31. PubMed ID: 2499021
[TBL] [Abstract][Full Text] [Related]
14. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
[TBL] [Abstract][Full Text] [Related]
15. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
Rossi F; Kazatchkine MD
J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
[TBL] [Abstract][Full Text] [Related]
16. Anti CD5 sustains the proliferative response of IgM-activated human CD5+ B cells.
Jamin C; Dueymes M; Lydyard PM; Youinou P
Scand J Immunol; 1995 Aug; 42(2):282-5. PubMed ID: 7543217
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
[TBL] [Abstract][Full Text] [Related]
19. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.
Schaub A; von Gunten S; Vogel M; Wymann S; Rüegsegger M; Stadler BM; Spycher M; Simon HU; Miescher S
Allergy; 2011 Aug; 66(8):1030-7. PubMed ID: 21385183
[TBL] [Abstract][Full Text] [Related]
20. B-1 cells in systemic autoimmune responses: IgM+, Fc epsilon Rdull B cells are lost during chronic graft-versus-host disease but not in murine AIDS or collagen-induced arthritis.
Iciek LA; Waldschmidt TJ; Griffiths MM; Brooks KH
Immunol Invest; 1994 Aug; 23(4-5):293-311. PubMed ID: 7525472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
